top of page


Pfizer’s $5.4bn Acquisition of Global Blood Therapeutics
By Matilda Oculy and Filip Stoilov (The University of Manchester), Ritu Joseph (London Business School) Photo: CDC (Unsplash) Overview of...

The MergerSight Group
Feb 8, 20234 min read


GSK’s Demerger of Haleon
By Nancy Huang (University of Melbourne), Fuh Zhe Yi, Ahaan Roychowdhury and Harold Parra Halder (University College London) Photo: Mika...

The MergerSight Group
Feb 1, 20236 min read


AstraZeneca’s $1.8bn Acquisition of CinCor Pharma
By Albert Ibekwe (University of St Andrews), Athean Myat, Evan Schnell, James Ludlow and Nina Choophungart (Cornell University) Photo:...

The MergerSight Group
Jan 26, 20234 min read


Amgen’s $28bn Acquisition of Horizon Therapeutics
By Sameer Jain, Ishan Date and Michael Akullo (Wharton School), Fuh Zhe Yi, Ahaan Roychowdhury and Harold Parra Holder (University...

The MergerSight Group
Jan 6, 20234 min read


VillageMD’s $8.9bn Acquisition of Summit Health
By Xunliang Huang (the University of Melbourne) and Matilda Oculy, Filip Stoilov (The University of Manchester) Photo: Derek Finch...

The MergerSight Group
Jan 4, 20234 min read


Johnson & Johnson’s $16.6bn Acquisition of Abiomed
By William Dinsdale and Bilal Rashid (LSE), Priyanshu Srivastava, Amarthya Chandrappa, and Deepankumar Sakthive (Warwick) Photo: Jesse...

The MergerSight Group
Nov 27, 20224 min read


CVS’ $8bn Acquisition of Signify Health
By William Dinsdale and Bilal Rashid (LSE), Friedrich von Storch, Enrique Perez-Hernandez and Ties Oudmayer (IE) Photo: Nathaniel Yeo...

The MergerSight Group
Nov 7, 20224 min read


Kroger’s $24.6bn Acquisition of Albertsons
By Matilda Oculy and Filip Stoilov (University of Manchester), Sameer Jain and Micheal Akullo (Wharton School) Photo: No Revisions...

The MergerSight Group
Oct 31, 20225 min read


Amazon’s $3.9bn Acquisition of One Medical
By Jack Lee, Heather Leung and Terry Au-Yeung (HKUST), Sonia Andrzejuk, Argyro Charizona and Vlad Marcu (Bocconi) Photo: Hyttalo Souza...

The MergerSight Group
Oct 19, 20225 min read


Novartis’ spin-off of Sandoz business
By Sameer Jain (Wharton School), Eden Yang (London School of Economics) Photo: Freestocks (Unsplash) Overview of the deal Parent:...

The MergerSight Group
Sep 12, 20224 min read


Pfizer $11.6bn Acquisition of Biohaven
By Justin Leung, Jack Lee, Heather Leung, and Sissi Zeng (Hong Kong University of Science and Technology) Photo: Christina Victoria...

The MergerSight Group
Jun 12, 20224 min read


Stryker’s $3.09bn Acquisition of Vocera Communications
By Matilda Oculy, Aadit Jain, András Szabó, and Deimantė Chailenko (Manchester), Joshua Ooi, Ayushman Nath, Danissa Wan, Jack Wu, and...

The MergerSight Group
Jan 26, 20224 min read


Merck’s $11.5bn Acquisition of Acceleron Pharma
By Tudor Popescu and Bella Chen (University of Chicago), Ivan Chung, Justin Leung, and Ryan Chan (HKUST) Photo: Louis Reed (Unsplash)...

The MergerSight Group
Oct 13, 20215 min read


Sanofi’s Acquisition of Kymab
By Lorenzo Mirone, Riccardo Colombo, Federico de Rosa (Bocconi University) and Roshni Padhi, Winston Shum, Moh Jin Yin (Stanford...

The MergerSight Group
Mar 10, 20214 min read


Jazz Pharmaceuticals’ $7.2bn Acquisition of GW Pharmaceuticals
By Edvard Bruu and Hannah Ohlsson (Stockholm School of Economics), Isabelle Duerbeck and Tim Bamberger (King’s College London) Photo:...

The MergerSight Group
Feb 23, 20215 min read


Pharmaceutical M&A
By Gurneek Gill (UCL), Nihat Anwar (SSE), Mustafa Bayramli (Wharton) Photo: Myriam Zilles (Unsplash) I. Industry Background The...

The MergerSight Group
Feb 1, 20217 min read


AstraZeneca to acquire Alexion in $39bn deal
By Itai Almogy, Gaspard Baroudel, Raphael Berz (Yale University), and Nathan Walemba (Oxford University) Photo: Julia Koblitz (Unsplash)...

The MergerSight Group
Jan 12, 20214 min read


Illumina’s $8bn Acquisition of GRAIL
By Vinay Naik (University of Warwick), Roshni Padhi, Amarins Laanstra-Corn and Winston Shum (Stanford University) Overview of the deal...

The MergerSight Group
Oct 5, 20204 min read


Gilead Sciences Inc.’s $21bn Acquisition of Immunomedics
By Jinghan Jennifer, Sanjana Ramaswamy, William Zhang (St Andrews), Mariana Velasco, Anthony Borgese, Mustafa Bayramli, Susan Xiao & Zen...

The MergerSight Group
Sep 28, 20205 min read


Nestlé's $2.6 Billion Acquisition of Aimmune Therapeutics
By Edvard Bruu and Wilma Tillqvist (Stockholm School of Economics), Aman Singla, Akhil Anand Vajjhala and Siddharth Tripurani (New York...

The MergerSight Group
Sep 14, 20204 min read
bottom of page
